Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
T cells from ART-suppressed individuals can originate from biologically competent proviruses.
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
Design and implementation of the multi-arm, multi-stage Therapeutics for Inpatients with COVID-19 (TICO) platform master protocol: An Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative.
The Aging Imageomics Study: rationale, design and baseline characteristics of the study population.
The EuroSIDA study: 25 years of scientific achievements.
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients.